Delivery Order SPE2DR25D3301-SPE2DR26F20BS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.22 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,260.01 on December 4, 2025, for the supply of epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed price delivery order with an ultimate completion date of December 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) valued at $2,995.40. This competitively awarded, firm fixed-price delivery order was issued on December 18, 2025, with an ultimate completion date of December 19, 2025. The contract represents a small-value pharmaceutical procurement executed under DLA's medical supply chain operations, with performance to be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,878.44 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price, non-set-aside delivery order was awarded on November 15, 2025, with an ultimate completion date of November 17, 2025. The product will be performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency has awarded a delivery order valued at $1,797.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date is November 18, 2025, with the award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,865.81 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 MG auto-injector two-packs. This competitive award, with an ultimate completion date of September 3, 2025, was issued as a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.11 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 10, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,855.35 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3mg auto-injectors (2-pack). This firm fixed-price delivery order, awarded on December 30, 2025, is scheduled for completion by January 28, 2026, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. The contract was competitively awarded without set-aside restrictions, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector, 2-pack units, with a ceiling value of $3,617.54. This non-competed delivery order was awarded on December 29, 2025, with an ultimate completion date of December 30, 2025, and represents a firm fixed-price transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,578.79 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack). This competitively awarded, firm fixed-price delivery order was issued on December 22, 2025, with an ultimate completion date of December 23, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized in this procurement. This...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20BSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,781.32 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order was established on December 31, 2025, with an ultimate completion date of January 2, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The broader IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of medications, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal healthcare systems worldwide. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen maintains a significant portfolio of competitively awarded federal contracts with the DLA Medical Supply Chain, demonstrating consistent capability to fulfill critical pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/30/25 |